UNLABELLED: Pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) is successful in ∼70-80 % after repeated procedures. This suggests a subgroup of PAF patients where electrical abnormalities outside the pulmonary veins are important. Prolonged P-wave duration (PWD), a marker of atrial remodelling, may identify this subgroup. This study's aim was to assess the association of PWD on standard 12 lead ECG with AF recurrence post PVI. METHODS: Retrospectively, ECGs were blindly analysed on PVI patients from August 2007-August 2011; patients with persistent AF, mitral valve disease, undergoing redo procedures or no sinus rhythm (SR) ECG within 1 year of PVI were excluded. ECGs were directly uploaded at 300 dpi, amplified ×10, and then PWD measured in all leads. Prolonged PWD was as priori defined as maximum PWD ≥ 140 ms. RESULTS: The selective cohort consisted of 100 patients out of a total of 170 PVI: age 58 ± 11 years, 72 % male, LVEF 62 ± 9 %, 18 % ischaemic heart disease and 13 % diabetic. Thirty-five had prolonged PWD, which was associated with greater AF recurrence rates compared to those without prolonged PWD (63 vs. 38 %, p < 0.05). Similarly, AF recurrence was associated with greater maximum PWD (139 ± 17 vs. 129 ± 14, p < 0.01), P-wave dispersion (58 ± 21 vs. 49 ± 15, p < 0.01), left atrium (LA) dimension (41 ± 6 vs. 38 ± 5, p < 0.05) and LA volumes (40 ± 14 vs. 34 ± 11, p < 0.05) compared to those who remained in SR. None of these variables were independent predictors of AF recurrence by multivariate analysis. CONCLUSION: The presence of pre-existent prolonged PWD is associated with a higher risk of AF recurrence post PVI for paroxysmal AF.
UNLABELLED: Pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) is successful in ∼70-80 % after repeated procedures. This suggests a subgroup of PAF patients where electrical abnormalities outside the pulmonary veins are important. Prolonged P-wave duration (PWD), a marker of atrial remodelling, may identify this subgroup. This study's aim was to assess the association of PWD on standard 12 lead ECG with AF recurrence post PVI. METHODS: Retrospectively, ECGs were blindly analysed on PVI patients from August 2007-August 2011; patients with persistent AF, mitral valve disease, undergoing redo procedures or no sinus rhythm (SR) ECG within 1 year of PVI were excluded. ECGs were directly uploaded at 300 dpi, amplified ×10, and then PWD measured in all leads. Prolonged PWD was as priori defined as maximum PWD ≥ 140 ms. RESULTS: The selective cohort consisted of 100 patients out of a total of 170 PVI: age 58 ± 11 years, 72 % male, LVEF 62 ± 9 %, 18 % ischaemic heart disease and 13 % diabetic. Thirty-five had prolonged PWD, which was associated with greater AF recurrence rates compared to those without prolonged PWD (63 vs. 38 %, p < 0.05). Similarly, AF recurrence was associated with greater maximum PWD (139 ± 17 vs. 129 ± 14, p < 0.01), P-wave dispersion (58 ± 21 vs. 49 ± 15, p < 0.01), left atrium (LA) dimension (41 ± 6 vs. 38 ± 5, p < 0.05) and LA volumes (40 ± 14 vs. 34 ± 11, p < 0.05) compared to those who remained in SR. None of these variables were independent predictors of AF recurrence by multivariate analysis. CONCLUSION: The presence of pre-existent prolonged PWD is associated with a higher risk of AF recurrence post PVI for paroxysmal AF.
Authors: Marco Budeus; Marcus Hennersdorf; Christian Perings; Heinrich Wieneke; Raimund Erbel; Stefan Sack Journal: Ann Noninvasive Electrocardiol Date: 2005-10 Impact factor: 1.468
Authors: C Medi; P B Sparks; J B Morton; P M Kistler; K Halloran; R Rosso; J K Vohra; S Kumar; J M Kalman Journal: J Cardiovasc Electrophysiol Date: 2010-08-31
Authors: Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders Journal: Heart Rhythm Date: 2010-01-22 Impact factor: 6.343
Authors: Adrian Baranchuk; Helen Pang; Geoffrey E J Seaborn; Payam Yazdan-Ashoori; Damian P Redfearn; Christopher S Simpson; Kevin A Michael; Michael Fitzpatrick Journal: J Interv Card Electrophysiol Date: 2012-11-21 Impact factor: 1.900
Authors: Ankit Maheshwari; Faye L Norby; Elsayed Z Soliman; M Chadi Alraies; Selcuk Adabag; Wesley T O'Neal; Alvaro Alonso; Lin Y Chen Journal: Am J Cardiol Date: 2017-02-09 Impact factor: 2.778
Authors: Marco Marano; Anna D'Amato; Antoni Bayés de Luna; Adrian Baranchuk Journal: Ann Noninvasive Electrocardiol Date: 2014-12-26 Impact factor: 1.468
Authors: Fariha Sadiq Ali; Andres Enriquez; Diego Conde; Damian Redfearn; Kevin Michael; Christopher Simpson; Hoshiar Abdollah; Antoni Bayés de Luna; Wilma Hopman; Adrian Baranchuk Journal: Ann Noninvasive Electrocardiol Date: 2015-02-02 Impact factor: 1.468
Authors: Adrian Baranchuk; Diego Conde; Andres Enriquez; Antoni Bayés de Luna Journal: Ann Noninvasive Electrocardiol Date: 2014-05-14 Impact factor: 1.468
Authors: Antoni Bayés de Luna; Adrian Baranchuk; Manuel Martínez-Sellés; Pyotr G Platonov Journal: Ann Noninvasive Electrocardiol Date: 2016-12-16 Impact factor: 1.468
Authors: Enes E Gul; Raveen Pal; Jane Caldwell; Usama Boles; Wilma Hopman; Benedict Glover; Kevin A Michael; Damian Redfearn; Chris Simpson; Hoshiar Abdollah; Adrian Baranchuk Journal: Ann Noninvasive Electrocardiol Date: 2016-12-25 Impact factor: 1.468